Your browser doesn't support javascript.
loading
Intralymphatic immunotherapy in pollen-allergic young adults with rhinoconjunctivitis and mild asthma: A randomized trial.
Konradsen, Jon R; Grundström, Jeanette; Hellkvist, Laila; Tran, Thi Anh Thu; Andersson, Niklas; Gafvelin, Guro; Kiewiet, M B Gea; Hamsten, Carl; Tang, Jiaqian; Parkin, Rebecca V; Shamji, Mohamed H; Hedlin, Gunilla; Cardell, Lars-Olaf; van Hage, Marianne.
  • Konradsen JR; Department of Medicine Solna, Division of Immunology and Allergy, Karolinska Institutet and University Hospital, Stockholm, Sweden; Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, S
  • Grundström J; Department of Medicine Solna, Division of Immunology and Allergy, Karolinska Institutet and University Hospital, Stockholm, Sweden.
  • Hellkvist L; Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden; Department of ENT Diseases, Karolinska University Hospital, Stockholm, Sweden.
  • Tran TAT; Department of Medicine Solna, Division of Immunology and Allergy, Karolinska Institutet and University Hospital, Stockholm, Sweden.
  • Andersson N; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Gafvelin G; Therapeutic Immune Design Unit, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Kiewiet MBG; Department of Medicine Solna, Division of Immunology and Allergy, Karolinska Institutet and University Hospital, Stockholm, Sweden.
  • Hamsten C; Department of Medicine Solna, Division of Immunology and Allergy, Karolinska Institutet and University Hospital, Stockholm, Sweden.
  • Tang J; Immunomodulation and Tolerance Group, Allergy and Clinical Immunology, Section of Inflammation, Repair and Development, National Heart and Lung Institute, Imperial College, London, United Kingdom; MRC & Asthma UK Centre in Allergic Mechanisms of Asthma, London, United Kingdom.
  • Parkin RV; Immunomodulation and Tolerance Group, Allergy and Clinical Immunology, Section of Inflammation, Repair and Development, National Heart and Lung Institute, Imperial College, London, United Kingdom; MRC & Asthma UK Centre in Allergic Mechanisms of Asthma, London, United Kingdom.
  • Shamji MH; Immunomodulation and Tolerance Group, Allergy and Clinical Immunology, Section of Inflammation, Repair and Development, National Heart and Lung Institute, Imperial College, London, United Kingdom; MRC & Asthma UK Centre in Allergic Mechanisms of Asthma, London, United Kingdom.
  • Hedlin G; Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
  • Cardell LO; Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden; Department of ENT Diseases, Karolinska University Hospital, Stockholm, Sweden.
  • van Hage M; Department of Medicine Solna, Division of Immunology and Allergy, Karolinska Institutet and University Hospital, Stockholm, Sweden. Electronic address: Marianne.van.Hage@ki.se.
J Allergy Clin Immunol ; 145(3): 1005-1007.e7, 2020 03.
Article en En | MEDLINE | ID: mdl-31775016

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas de Plantas / Asma / Conjuntivitis Alérgica / Rinitis Alérgica Estacional / Desensibilización Inmunológica / Antígenos de Plantas Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Female / Humans / Male Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas de Plantas / Asma / Conjuntivitis Alérgica / Rinitis Alérgica Estacional / Desensibilización Inmunológica / Antígenos de Plantas Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Female / Humans / Male Idioma: En Año: 2020 Tipo del documento: Article